Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-034069

Options or other derivatives

  • Director acquired 250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KING STEVEN W · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-10 Grant or award : show line 1 in the form Restricted stock Units +250 250 D
Loading xslF345X06/ownership.xml…